Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
OptimizeRx Corp.

OptimizeRx Corp. (OPRX) Stock Overview

Explore OptimizeRx Corp.’s financial performance, market position, analyst ratings, and future outlook.

OPRX●NASDAQ
HealthcareMedical - Healthcare Information Services
$8.36
$0.55(7.04%)
U.S. Market opens in 13h 48m

OptimizeRx Corp. (OPRX)

Meyka AI Score

Z

Key Financials

Market Cap156.9M
P/E Ratio34.28
EPS (TTM)$1.09
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$8.64
3 Months$0.40
1 Year Target$4.21

OPRX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of OptimizeRx Corp. (NASDAQ: OPRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, OptimizeRx Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OPRX on the NASDAQ shows an RSI of 63.28, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.21 for the NASDAQ listing.

Key metrics behind OptimizeRx Corp.'s NASDAQ-traded stock include a P/E ratio of 34.28 and a market capitalization of 156.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OPRX on the NASDAQ.

Price Performance (NASDAQ: OPRX)

1-Day Change
7.04%
5-Day Change
11.32%
1-Month Change
5.16%
3-Month Change
53.96%
6-Month Change
26.67%
Year-to-Date (YTD) Change
-31.81%
1-Year Change
-59.24%
3-Year Change
7.46%
5-Year Change
-88.85%
All-Time (Max) Change
-76.78%

Contact Information

https://www.optimizerx.com
248 651 6568
260 Charles Street, Waltham, MA, 02453

Company Facts

1,330 Employees
IPO DateNov 28, 2007
CountryUS
Actively Trading

Frequently Asked Questions